Non-contrast-enhanced breast MRI for evaluation of tumor volume change after neoadjuvant chemotherapy
-
Published:2024-08
Issue:
Volume:177
Page:111555
-
ISSN:0720-048X
-
Container-title:European Journal of Radiology
-
language:en
-
Short-container-title:European Journal of Radiology
Author:
Harada Taiyo LORCID,
Uematsu TakayoshiORCID,
Nakashima Kazuaki,
Sugino Takashi,
Nishimura Seiichirou,
Takahashi Kaoru,
Hayashi Tomomi,
Tadokoro Yukiko
Reference40 articles.
1. MRI, Clinical Examination, and Mammography for Preoperative Assessment of Residual Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: ACRIN 6657 Trial;Scheel;AJR Am. J. Roentgenol.,2018
2. Comparison of mammography, digital breast tomosynthesis, automated breast ultrasound, magnetic resonance imaging in evaluation of residual tumor after neoadjuvant chemotherapy;Park;Eur. J. Radiol.,2018
3. Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer;Li;Invest. Radiol.,2015
4. Evaluation of the treatment response to neoadjuvant chemotherapy in locally advanced breast cancer using combined magnetic resonance vascular maps and apparent diffusion coefficient;Wu;J. Magn. Reson. Imaging,2015
5. Diffusion-weighted MR imaging of locally advanced breast carcinoma: the optimal time window of predicting the early response to neoadjuvant chemotherapy;Yuan;Cancer Imaging,2018